SeaStar Medical Holding Corporation
ICU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -45.9% | 15.4% | 337.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.3% | 92% | 100% | 100% |
| R&D Expenses | $2 | $1 | $2 | $3 |
| G&A Expenses | $2 | $1 | $2 | $2 |
| SG&A Expenses | $2 | $1 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $2 | $4 | $5 |
| Operating Income | -$4 | -$2 | -$4 | -$5 |
| % Margin | -1,955.7% | -519.5% | -1,304.4% | -7,114.9% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$3 | -$2 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$4 | -$4 |
| % Margin | -1,897.3% | -592.3% | -1,287.4% | -6,595.5% |
| EPS | -0.13 | -0.11 | -0.44 | -0.9 |
| % Growth | -18.2% | 75% | 51.1% | – |
| EPS Diluted | -0.13 | -0.11 | -0.44 | -0.9 |
| Weighted Avg Shares Out | 26 | 18 | 9 | 5 |
| Weighted Avg Shares Out Dil | 26 | 18 | 9 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | -$0 |
| Depreciation & Amortization | $0 | $0 | $0 | -$0 |
| EBITDA | -$3 | -$2 | -$4 | -$5 |
| % Margin | -1,893.4% | -589.6% | -1,282.6% | -6,973.1% |